Icalcaprant is a kappa-opioid receptor antagonist[1].
References
[1] Arora, et al. Preparation of heteroarylphenoxy benzamide κ-opioid ligands for the treatment of neurological and psychiatric disorders. World Intellectual Property Organization, WO2018096510 A1. 2018-05-31.
